Atypical Femoral Fracture Post Total HIP Replacement in a Patient with HIP Osteoarthritis and an Ipsilateral Cortical Thickening

Introduction Atypical femoral fractures (AFF) can be present in patients with hip osteoarthritis (OA). This case highlights the opportunity to review the management of stress reactions, stress fractures and atypical femoral fractures, which depend on the activity of the fracture. Case presentation A 66-year-old female with a history of long-term bisphosphonate use underwent a total hip replacement for symptomatic osteoarthritis with a clinical presentation of right groin pain and radiographic signs of joint space narrowing and osteophyte formation. Radiographs before hip arthroplasty showed lateral cortical thickening in the ipsilateral femur in the subtrochanteric region. The patient developed a complete periprosthesic atypical femoral fracture a month after surgery at the level of the previously identified femoral cortical thickening. Discussion Given the high amount of elderly, osteoporotic patients presenting with groin/thigh pain undergoing hip replacement, surgeons should question them about the use of bisphosphonates in the past and look for the presence of AFF. These should receive bilateral imaging studies and a metabolic bone workup in order to define the status of the fracture and determine the appropriate management before considering any other surgical intervention.

[1]  J. Lane,et al.  Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection. , 2013, The Journal of bone and joint surgery. American volume.

[2]  J. Weinstein,et al.  The influence of obesity on the outcome of treatment of lumbar disc herniation: analysis of the Spine Patient Outcomes Research Trial (SPORT). , 2013, The Journal of bone and joint surgery. American volume.

[3]  Yuh‐Min Cheng,et al.  Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report , 2012, Menopause.

[4]  M. Ahlman,et al.  Evolution of bisphosphonate‐related atypical fracture retrospectively observed with DXA scanning , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Thomas D Brown,et al.  Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  D. Black,et al.  Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  D. Lorich,et al.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. , 2008, The New England journal of medicine.

[8]  T. Howe,et al.  Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. , 2007, The Journal of bone and joint surgery. British volume.

[9]  M. Swiontkowski,et al.  Bisphosphonate Use and Atypical Fractures of the Femoral Shaft , 2012 .

[10]  B. Manaster Low-Energy Femoral Shaft Fractures Associated With Alendronate Use , 2009 .

[11]  R. Heaney Osteoporosis: management and treatment strategies for orthopaedic surgeons. , 2008, Journal of Bone and Joint Surgery. American volume.